Skip to main content

Table 1 Volume and dose comparisons among plans generated from 3D-CRT with FB, T-DIBH and A-DIBH

From: Abdominal DIBH reduces the cardiac dose even further: a prospective analysis

 

3D-CRT plans

P value

Parameters

FB

T-DIBH

A-DIBH

FB v.s. T

FB v.s.A

T v.s. A

PTV

 Volume (cm3)

674.14±244.51

673.77±249.54

673.81±246.49

N.S.

N.S.

N.S.

 Mean (Gy)

51.61±14.37

51.41±14.65

51.46±13.63

N.S.

N.S.

N.S.

 D2% (Gy)

53.88±15.13

53.76±15.37

53.83±13.84

N.S.

N.S.

N.S.

 V105% (%)

26.58±22.70

26.51±21.17

26.55±19.27

N.S.

N.S.

N.S.

 HI (%)

15.49±1.95

15.34±1.89

15.46±1.72

N.S.

N.S.

N.S.

Heart

 Volume (cm3)

549.54±88.01

504.83±69.55

479.53±74.44

**

***

*

 Mean (Gy)

2.89±1.30

1.67±0.90

1.34±0.43

***

***

***

 D2% (Gy)

31.25±16.99

12.11±13.22

6.53±4.05

***

***

***

 V5 (%)

7.78±4.20

3.68±3.21

2.57±2.05

***

***

**

 V10 (%)

4.57±3.07

1.65±2.14

0.93±1.17

***

***

**

 V20 (%)

3.26±2.62

1.05±1.68

0.53±0.77

***

***

*

 V30 (%)

2.62±2.26

0.78±1.40

0.36±0.57

***

***

*

LADCA

 Volume (cm3)

0.80±0.12

0.80±0.13

0.80±0.10

N.S.

N.S.

N.S.

 Mean (Gy)

29.08±16.72

13.94±14.74

10.22±10.30

***

***

***

 D2% (Gy)

37.59±17.58

22.03±18.02

18.45±16.52

***

***

**

 V5 (%)

87.69±24.39

54.94±39.17

49.42±40.11

***

***

*

 V10 (%)

66.02±37.45

32.36±39.20

26.41±37.24

***

***

*

 V20 (%)

57.39±41.18

23.37±36.48

18.22±31.57

***

***

*

 V30 (%)

52.94±40.24

19.10±34.19

12.55±25.01

***

***

N.S.

Left lung

 Volume (cm3)

1022.22±223.48

1541.81±324.32

1663.36±270.93

***

***

N.S.

 Mean (Gy)

7.77±2.71

7.32±1.42

6.90±1.60

*

*

*

 D2% (Gy)

46.67±5.06

46.16±2.89

45.31±3.01

*

**

***

 V5 (%)

25.53±7.35

25.84±4.13

24.94±4.80

N.S.

N.S.

N.S.

 V10 (%)

17.63±6.23

16.99±3.36

15.96±4.05

N.S.

N.S.

*

 V20 (%)

13.37±5.77

12.32±3.09

11.26±3.68

N.S.

*

*

 V30 (%)

11.34±5.62

10.29±3.15

9.28±3.48

N.S.

*

**

  1. Note: * <0.05, ** <0.01,*** <0.001, N.S.: not significant